✦ LIBER ✦

Increased antigen presenting cell-mediated T cell activation in mice and patients without the autoimmune regulator

✍ Scribed by Chris Ramsey; Signe Hässler; Per Marits; Olle Kämpe; Charles D. Surh; Leena Peltonen; Ola Winqvist

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 416 KB
Volume: 36
Category: Article
ISSN: 0014-2980
DOI: 10.1002/eji.200535240

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Simvastatin impairs humoral and cell-med

Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation

✍ Cristina Ulivieri; Daniela Fanigliulo; Daniela Benati; Franco Laghi Pasini; Cosi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 462 KB 👁 1 views

Autoimmune hepatitis and antigen-specifi

Autoimmune hepatitis and antigen-specific T regulatory cells: When can we send in the regulators?

✍ John M. Vierling 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

FcγR receptors activate MAP kinase and u

FcγR receptors activate MAP kinase and up-regulate the cyclooxygenase pathway without increasing arachidonic acid release in monocytic cells

✍ Nieves Fernández; Marta Renedo; Mariano Sánchez Crespo 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Heparanase prevents the development of t

Heparanase prevents the development of type 1 diabetes in non-obese diabetic mice by regulating T-cell activation and cytokines production

✍ Menachem Bitan; Lola Weiss; Michael Zeira; Shoshana Reich; Orit Pappo; Israel Vl 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 216 KB

## Abstract ## Background Heparanase is an endo‐β‐D‐glucuronidase that cleaves heparan sulfate saccharide chains. The enzyme promotes cell adhesion, migration and invasion, and was shown to play a significant role in cancer metastasis and angiogenesis. ## Methods The present study focuses on the

Extracellular calreticulin is present in

Extracellular calreticulin is present in the joints of patients with rheumatoid arthritis and inhibits FasL (CD95L)–mediated apoptosis of T cells

✍ Joanna M. Tarr; Paul G. Winyard; Brent Ryan; Lorna W. Harries; Richard Haigh; Ni 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Treatment of the P815 murine mastocytoma

Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibody-mediated cytotoxicity and to lysis by anti-CD3-activated killer-T cells

✍ Brent A. Williams; Andrew P. Makrigiannis; Jonathan Blay; David W. Hoskin 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB 👁 2 views

We have investigated the effect of pre-treatment with the anti-cancer drugs cisplatin and etoposide on the susceptibility of P815 murine mastocytoma cells to lysis by murine spleen-derived anti-CD3-activated killer-T (AK-T) cells. A 20 hr pre-treatment with cisplatin (0.2-2 microg/ml) or etoposide (